Fj. Veith et al., Current status of carotid bifurcation angioplasty and stenting based on a consensus of opinion leaders, J VASC SURG, 33(2), 2001, pp. S111-S116
Citations number
13
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective: Carotid bifurcation angioplasty and stenting (CBAS) has generate
d controversy and widely divergent opinions about its current therapeutic r
ole. To resolve differences and establish a unified view of CBAS' present r
ole, a consensus conference of 17 experts, world opinion leaders from five
countries, was held on November 21, 1999.
Methods: These 17 participants had previously answered 18 key questions on
current CBAS issues. At the conference these 18 questions and participants'
answers were discussed and in some cases modified to determine points of a
greement (consensus), near consensus, (prevailing opinion), or divided opin
ion (disagreement).
Results: Conference discussion added two modified questions, placing a tota
l of 20 key questions before the participants, representing four specialtie
s (interventional radiology, seven; vascular surgery, six; interventional c
ardiology, three; neurosurgery, one). It is interesting that consensus was
reached on the answers to 11 (55%) of 20 of the questions, and near consens
us was reached on answers to 6 (30%) of 20 of the questions. Only with the
answers to three (15%) of the questions was there persisting controversy. M
oreover, both these differences and areas of agreement crossed specialty li
nes.
Consensus Conclusions: CBAS should not currently undergo widespread practic
e, which should await results of randomized trials. CBAS is currently appro
priate treatment for patients at high risk in experienced centers. CBAS is
not generally appropriate for patients at low risk. Neurorescue skills shou
ld be available if CBAS is performed. When cerebral protection devices are
available, they should be used for CBAS. Adequate stents and technology for
performing CBAS currently exist. There were divergent opinions regarding t
he proportions of patients presently acceptable for CBAS treatment (<5% to
100%, mean 44%) and best treated by CBAS (<3% to 100%, mean 34%). These and
other consensus conclusions will help physicians in all specialties deal w
ith CBAS in a rational way rather than by being guided by unsubstantiated c
laims.